Thc Therapeutics Stock Market Value
| THCT Stock | USD 0.0002 0.0001 33.33% |
| Symbol | THC |
THC Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to THC Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of THC Therapeutics.
| 03/10/2023 |
| 02/27/2025 |
If you would invest 0.00 in THC Therapeutics on March 10, 2023 and sell it all today you would earn a total of 0.00 from holding THC Therapeutics or generate 0.0% return on investment in THC Therapeutics over 720 days. THC Therapeutics is related to or competes with MERCK Kommanditgesells, Eisai, and C21 Investments. It is involved in the development of dHydronator, a sanitizing herb dryer for drying and sanitizing of freshly harvested... More
THC Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure THC Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess THC Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0783 | |||
| Maximum Drawdown | 233.33 | |||
| Potential Upside | 16.67 |
THC Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for THC Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as THC Therapeutics' standard deviation. In reality, there are many statistical measures that can use THC Therapeutics historical prices to predict the future THC Therapeutics' volatility.| Risk Adjusted Performance | 0.0674 | |||
| Jensen Alpha | 2.17 | |||
| Total Risk Alpha | 2.42 | |||
| Treynor Ratio | (8.22) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of THC Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
THC Therapeutics Backtested Returns
THC Therapeutics is out of control given 3 months investment horizon. THC Therapeutics retains Efficiency (Sharpe Ratio) of 0.0809, which indicates the firm had a 0.0809 % return per unit of volatility over the last 3 months. We were able to break down twenty-one different technical indicators, which can help you to evaluate if expected returns of 2.32% are justified by taking the suggested risk. Use THC Therapeutics risk adjusted performance of 0.0674, and Standard Deviation of 27.85 to evaluate company specific risk that cannot be diversified away. THC Therapeutics holds a performance score of 6 on a scale of zero to a hundred. The entity owns a Beta (Systematic Risk) of -0.26, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning THC Therapeutics are expected to decrease at a much lower rate. During the bear market, THC Therapeutics is likely to outperform the market. Use THC Therapeutics total risk alpha, as well as the relationship between the rate of daily change and relative strength index , to analyze future returns on THC Therapeutics.
Auto-correlation | 0.40 |
Average predictability
THC Therapeutics has average predictability. Overlapping area represents the amount of predictability between THC Therapeutics time series from 10th of March 2023 to 4th of March 2024 and 4th of March 2024 to 27th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of THC Therapeutics price movement. The serial correlation of 0.4 indicates that just about 40.0% of current THC Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.4 | |
| Spearman Rank Test | -0.14 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
THC Therapeutics lagged returns against current returns
Autocorrelation, which is THC Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting THC Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of THC Therapeutics returns to help us make a trade decision. For example, suppose you find that THC Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
THC Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If THC Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if THC Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in THC Therapeutics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
THC Therapeutics Lagged Returns
When evaluating THC Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of THC Therapeutics pink sheet have on its future price. THC Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, THC Therapeutics autocorrelation shows the relationship between THC Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in THC Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for THC Pink Sheet Analysis
When running THC Therapeutics' price analysis, check to measure THC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Therapeutics is operating at the current time. Most of THC Therapeutics' value examination focuses on studying past and present price action to predict the probability of THC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Therapeutics' price. Additionally, you may evaluate how the addition of THC Therapeutics to your portfolios can decrease your overall portfolio volatility.